e-ISSN: Pending
Failure-mode index

Search what already failed

A searchable index of real negative results, null findings, and replication failures from the published literature — so you can learn what didn't work before repeating it.

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record (title, authors, DOI) compiled from open scholarly databases, with the abstract shown in full only where the paper is openly licensed (e.g. Creative Commons); otherwise a short excerpt is shown for reference under fair use. WASTE classifies each work by failure type; classifications are automated and approximate.

25 results in Replication Failure for "randomized controlled trial"

Replication FailureMedicine

Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index<subtitle>A Randomized Controlled Trial</subtitle>

F.G.R. Fowkes · 2010 · JAMA

CONTEXT: A low ankle brachial index (ABI) indicates atherosclerosis and an increased risk of cardiovascular and cerebrovascular events. Screening for a low ABI can identify an asymptomatic higher risk group potentially amenable to…

View details →DOI: 10.1001/jama.2010.221Cited by 624
Replication FailureOpen accessMathematics

Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations

Amelia Averitt, Chunhua Weng, Patrick Ryan et al. · 2020 · npj Digital Medicine

Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the real-world population on factors that induce HTE, the trials effect will not replicate. The RCTs eligibility criteria should identify the sub-population in which its evidence will replicate. However, the extent to which the eligibility criteria identify the appropriate population is unknown, which raises conce

View details →DOI: 10.1038/s41746-020-0277-8Cited by 141
Replication FailureOpen accessMedicine

Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease

Manaf AlQahtani, Abdulkarim Abdulrahman, Abdulrahman Almadani et al. · 2021 · Scientific Reports

Convalescent plasma (CP) therapy in COVID-19 disease may improve clinical outcome in severe disease. This pilot study was undertaken to inform feasibility and safety of further definitive studies. This was a prospective, interventional and randomized open label pilot trial in patients with severe COVID-19. Twenty COVID-19 patients received two 200 ml transfusions of convalescent patient CP over 24-h compared with 20 who received standard of care. The primary outcome was the requirement for ventilation (non-invasive or mechanical ventilation). The secondary outcomes were biochemical parameters

View details →DOI: 10.1038/s41598-021-89444-5Cited by 104
Replication FailureOpen accessMedicine

Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies.

Clark DuMontier, Hajime Uno, Tammy Hshieh et al. · 2022 · PubMed

We conducted a randomized controlled trial in older adults with hematologic malignancies to determine the impact of geriatrician consultation embedded in our oncology clinic alongside standard care. From February 2015 to May 2018,…

View details →DOI: 10.3324/haematol.2021.278802Cited by 29
Replication Failure

The Fragility of Statistically Significant Randomized Controlled Trials in Plastic Surgery

Brian Chin, Andrea Copeland, Lucas Gallo et al. · 2019 · Plastic & Reconstructive Surgery

Background: The fragility index has been proposed as a metric to evaluate the robustness of statistically significant findings in randomized controlled trials. It measures the number of events that a trial result relies on to maintain…

View details →DOI: 10.1097/prs.0000000000006102Cited by 21
Replication FailureMedicine

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).

Anthony T.�C. Chan, Edwin P. Hui, Roger K.C. Ngan et al. · 2017 · Journal of Clinical Oncology

6002 Background: The benefit of adjuvant CT in NPC is unclear. Post-RT EBV DNA predicts poor survival and may be a biomarker of subclinical residual disease. We conducted a biomarker driven RCT using post-RT EBV DNA to select high risk NPC…

View details →DOI: 10.1200/jco.2017.35.15_suppl.6002Cited by 21
Replication FailureMedicine

Prehospital Whole Blood in Traumatic Hemorrhage — A Randomized Controlled Trial

Jason Smith, Rebecca Cardigan, Emily Sanderson et al. · 2026 · New England Journal of Medicine

BACKGROUND: Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. METHODS: We conducted a pragmatic,…

View details →DOI: 10.1056/nejmoa2516043Cited by 9
Replication FailureOpen accessSocial Sciences

Integrated Motivational Strategies for Intimate Partner Violence Perpetrators with Substance Use: A Randomized Controlled Trial

Cristina Expósito-Álvarez, Manuel Roldán-Pardo, Gail Gilchrist et al. · 2024 · Psychosocial Intervention

Objective: Intimate partner violence (IPV) perpetrators with alcohol and/or other drug use problems (ADUPs) have been identified as one of the main high-risk and highly resistant groups of perpetrators requiring special attention in…

View details →DOI: 10.5093/pi2024a13Cited by 9
Replication FailureMedicine

Does Orthosis Improve Outcomes of Conservative Treatment in Trigger Fingers? A 3-Arm Prospective Randomized Controlled Trial.

Minkhorst K, Munn A, MacDermid J et al. · 2025 · Archives of physical medicine and rehabilitation

Objective To evaluate whether the addition of an orthosis improved the efficacy of cortisone injection for the nonoperative management of trigger finger. Design Block randomized controlled trial. Setting Outpatient hand clinic.…

View details →DOI: 10.1016/j.apmr.2025.05.015
Replication FailureMedicine

Perioperative Administration of Mirogabalin for Postoperative Pain Management Following Total Hip Arthroplasty: A Randomized Controlled Trial.

Takeda Y, Nakai T, Okamoto T et al. · 2026 · The Journal of arthroplasty

Background Mirogabalin, a selective α2δ-1 ligand, has been proposed to exhibit potent analgesic effects with fewer central nervous system (CNS) side effects than prior gabapentinoids. Its effectiveness for acute postoperative pain after…

View details →DOI: 10.1016/j.arth.2026.03.095
Replication FailureMedicine

Role of Case Management for Improving Cardiac Rehabilitation Participation in Women: A RANDOMIZED CONTROLLED TRIAL.

Khadanga S, Yant B, Savage PD et al. · 2026 · Journal of cardiopulmonary rehabilitation and prevention

Purpose Despite the benefits, cardiac rehabilitation (CR) is underutilized, particularly in women. Case management (CM) has been shown to reduce the risk of cardiovascular disease and improve health outcomes. The purpose of this study was…

View details →DOI: 10.1097/hcr.0000000000001040
Replication FailureMedicine

Enhancing patient education in cataract surgery using a conversational artificial intelligence chatbot: pilot randomized controlled trial.

Cardon de Lichtbuer P, Declerck W, Rosseel Q et al. · 2026 · Journal of cataract and refractive surgery

Purpose To evaluate the effectiveness and usability of a safety-first, clinician-validated conversational artificial intelligence (AI) chatbot for cataract surgery education compared with standard brochures. Setting University Hospital (UZ…

View details →DOI: 10.1097/j.jcrs.0000000000001856
Replication FailureMedicine

Individualized nutritional intervention compared with routine care for gestational diabetes prevention: a randomized controlled trial.

Wang L, Wang X, Zhang R et al. · 2025 · The American journal of clinical nutrition

Background Gestational diabetes mellitus (GDM) affects millions of females and their children. Effective dietary strategies for early prevention are controversial. Objectives This study aims to investigate whether an individualized…

View details →DOI: 10.1016/j.ajcnut.2025.03.006
Replication FailureOpen accessMedicine

Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome.

Wongkraisri C, Chusuwanrak K, Laocharoenkeat A et al. · 2025 · BMC cancer

Background Hand-foot syndrome (HFS) is a common adverse event of capecitabine causing treatment modifications. Topical urea cream can reduce sorafenib-induced hand-foot skin reaction. However, its benefit in preventing…

View details →DOI: 10.1186/s12885-025-13684-1
Replication FailureMedicine

Clinical efficacy of soft-tissue augmentation on tissue preservation at immediate implant sites: A randomized controlled trial.

Lee CT, Tran D, Tsukiboshi Y et al. · 2023 · Journal of clinical periodontology

Aim This randomized controlled trial aimed to investigate the efficacy of soft-tissue augmentation (STA) with a subepithelial connective tissue graft (SCTG) or an acellular dermal matrix (ADM) on reducing tissue alterations at an immediate…

View details →DOI: 10.1111/jcpe.13816
Replication FailureOpen accessMedicine

Cognitive control training as an add-on treatment for late-life depression: A multicenter randomized controlled trial.

Vander Zwalmen Y, Vrijsen JN, Meuleman B et al. · 2026 · Internet interventions

Background Late-life depression (LLD) is a prevalent and debilitating condition associated with a poor long-term prognosis and high rates of chronicity. Cognitive control impairments are common in LLD and contribute to symptom persistence,…

View details →DOI: 10.1016/j.invent.2026.100951
Replication FailureOpen accessMedicine

Medication Review and Enhanced Information Transfer at Discharge of Older Patients with Polypharmacy: a Cluster-Randomized Controlled Trial in Swiss Hospitals.

Grischott T, Rachamin Y, Senn O et al. · 2023 · Journal of general internal medicine

Background Medication safety in patients with polypharmacy at transitions of care is a focus of the current Third WHO Global Patient Safety Challenge. Medication review and communication between health care professionals are key targets to…

View details →DOI: 10.1007/s11606-022-07728-6
Replication FailureOpen accessMedicine

Liposomal Bupivacaine versus Ropivacaine with Dexamethasone in Rectus Sheath Block for Laparoscopic Gastrectomy: A Randomized Controlled Trial.

Yi K, Zhan Y, Wei A et al. · 2026 · Drug design, development and therapy

Background The optimal analgesia regimen for patients undergoing laparoscopic gastrectomy is still unclear. This study evaluated the efficacy of ultrasound-guided rectus sheath block (RSB) with liposomal bupivacaine in providing sustained…

View details →DOI: 10.2147/dddt.s574724
Replication FailureMedicine

Impact of Vitamin D Supplementation on IVF Outcomes in Vitamin D-Deficient Poor Responders: a Randomized Controlled Trial.

Mirsharifi MS, Shirdel S, Ghaderi E et al. · 2026 · Reproductive sciences (Thousand Oaks, Calif.)

OBJECTIVE: This study aimed to evaluate the effect of vitamin D supplementation on in vitro fertilization (IVF) outcomes in poor responder women with vitamin D deficiency, focusing on fertilization rates, oocyte quality, and pregnancy…

View details →DOI: 10.1007/s43032-025-02022-2
Replication FailureMedicine

Chest wall injury surgeon, know thyself.

Pieracci FM, Doben A, Eriksson E et al. · 2026 · The journal of trauma and acute care surgery

Abstract The use of surgical stabilization of rib fractures (SSRF) for non-flail fracture patterns continues to rise. However, multiple, recent randomized controlled trials in this patient population have failed to show a clear benefit to…

View details →DOI: 10.1097/ta.0000000000004723
Replication FailureOpen accessDiseases of the digestive system. Gastroenterology

Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line eradication: a prospective multicenter randomized controlled trial

Ben-Gang Zhou, Ming-Wen Guo, Li-Juan Zhang et al. · 2024 · Therapeutic Advances in Gastroenterology

Background: The efficacy of the 14-day esomeprazole–amoxicillin (EA) dual therapy in eradicating Helicobacter pylori ( H. pylori ) has been widely discussed previously. Vonoprazan, a novel potassium-competitive acid blocker, presents rapid, potent, and long-lasting acid inhibitory effects compared to esomeprazole. However, there is currently a scarcity of direct comparisons between the 10-day vonoprazan–amoxicillin (VA) and the 14-day EA dual therapy for H. pylori eradication. Objectives: This study aimed to compare the efficacy and safety of the 10-day VA and the 14-day EA dual therapy for H.

View details →DOI: 10.1177/17562848241309870
Replication FailureOpen accessMedicine

Pulmonary expansion manoeuvres compared to usual care on ventilatory mechanics, oxygenation, length of mechanical ventilation and hospital stay, extubation, atelectasis, and mortality of patients in mechanical ventilation: A randomized clinical trial.

Karina da Silva, Cristino Carneiro Oliveira, Leandro Ferracini Cabral et al. · 2023 · PLoS ONE

Pulmonary expansion manoeuvres are therapeutic techniques used to prevent and reverse atelectasis; however, no randomized controlled trials have provided evidence supporting the use of this intervention among individuals on mechanical ventilation. Objective To evaluate the effects of chest compression-decompression and chest block manoeuvres compared to usual care among patients on mechanical ventilation. Methods The current study was a randomized clinical trial of adult subjects on mechanical ventilation for 12 to 48 hours. The control group received usual care (passive or active mobilization

View details →DOI: 10.1371/journal.pone.0295775